Milestone Scientific Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-5.7M | $-4.7M | $-6.9M | $-8.7M | $-6.8M | $-7.3M | $-7.5M | $-7.4M |
| Depreciation & Amortization | $78.2K | $37.4K | $61.9K | $63.8K | $73.8K | $95.9K | $100.5K | $881.3K |
| Depreciation | $8.9K | $7.2K | $13.0K | $14.2K | $22.2K | $42.9K | $47.5K | $66.6K |
| Amortization | $69.3K | $30.2K | $49.3K | $49.7K | $51.6K | $53.0K | $53.0K | $814.7K |
| Stock-Based Compensation | $952.7K | $1.3M | $1.5M | $1.5M | $790.9K | $550.3K | $183.9K | $409.0K |
| Net Cash from Operating Activities | $-2.9M | $-2.9M | $-5.3M | $-6.0M | $-4.0M | $-7.0M | $-1.8M | $-1.6M |
| Investing Activities | ||||||||
| Capital Expenditures | $15.1K | $10.1K | — | $8.5K | $15.2K | $21.4K | $9.9K | $7.4K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-15.1K | $3.0M | $-3.0M | $-8.5K | $-15.2K | $-21.4K | $-9.9K | $-15.4K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $786.3K | $233.8K | $2.6M | $-8.5K | $4.6M | $19.7M | $2.6M | $-250.0K |
| Net Change in Cash | $-2.1M | $280.3K | $-5.7M | $-6.0M | $540.4K | $12.7M | $772.8K | $-1.9M |
| Free Cash Flow | $-2.9M | $-2.9M | — | $-6.0M | $-4.0M | $-7.0M | $-1.8M | $-1.6M |